Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS.

Macfarlane GJ, Pathan E, Jones GT, Dean LE.

Rheumatology (Oxford). 2020 Jan 28. pii: kez657. doi: 10.1093/rheumatology/kez657. [Epub ahead of print]

PMID:
31990352
2.

Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS).

Macfarlane GJ, Rotariu O, Jones GT, Pathan E, Dean LE.

Ann Rheum Dis. 2020 Feb;79(2):202-208. doi: 10.1136/annrheumdis-2019-216143. Epub 2019 Oct 29.

PMID:
31662321
3.

AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS).

Macfarlane GJ, Pathan E, Siebert S, Packham J, Gaffney K, Choy E, Sengupta R, Atzeni F, Martin KR, Jones GT, Dean LE.

BMC Rheumatol. 2019 May 20;3:19. doi: 10.1186/s41927-019-0066-7. eCollection 2019.

4.

Response to Wolfe. Letter to the Editor, "Fibromyalgia Criteria".

Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, Fitzcharles MA, Paiva ES, Staud R, Sarzi-Puttini P, Buskila D, Macfarlane GJ.

J Pain. 2019 Jun;20(6):741-742. doi: 10.1016/j.jpain.2019.02.003. Epub 2019 Feb 26. No abstract available.

PMID:
30822536
5.

Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the BSR Biologics Register for Ankylosing Spondylitis (BSRBR-AS).

Zhao S, Jones GT, Macfarlane GJ, Hughes DM, Dean LE, Moots RJ, Goodson NJ.

Rheumatology (Oxford). 2019 May 1;58(5):811-819. doi: 10.1093/rheumatology/key371.

PMID:
30561738
6.

AAPT Diagnostic Criteria for Fibromyalgia.

Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, Fitzcharles MA, Paiva ES, Staud R, Sarzi-Puttini P, Buskila D, Macfarlane GJ.

J Pain. 2019 Jun;20(6):611-628. doi: 10.1016/j.jpain.2018.10.008. Epub 2018 Nov 16. Review.

7.

Identifying Persons with Axial Spondyloarthritis At Risk of Poor Work Outcome: Results from the British Society for Rheumatology Biologics Register.

Macfarlane GJ, Shim J, Jones GT, Walker-Bone K, Pathan E, Dean LE.

J Rheumatol. 2019 Feb;46(2):145-152. doi: 10.3899/jrheum.180477. Epub 2018 Nov 1. Erratum in: J Rheumatol. 2019 Jul;46(7):867-868.

8.

Five Potentially Modifiable Factors Predict Poor Quality of Life in Ankylosing Spondylitis: Results from the Scotland Registry for Ankylosing Spondylitis.

Dean LE, Macfarlane GJ, Jones GT.

J Rheumatol. 2018 Jan;45(1):62-69. doi: 10.3899/jrheum.160411. Epub 2017 Aug 1.

PMID:
28765244
9.

Impact of Moving From a Widespread to Multisite Pain Definition on Other Fibromyalgia Symptoms.

Dean LE, Arnold L, Crofford L, Bennett R, Goldenberg D, Fitzcharles MA, Paiva ES, Staud R, Clauw D, Sarzi-Puttini P, Jones GT, Ayorinde A, Flüß E, Beasley M, Macfarlane GJ.

Arthritis Care Res (Hoboken). 2017 Dec;69(12):1878-1886. doi: 10.1002/acr.23214. Epub 2017 Nov 2.

10.

Disease Severity in Never Smokers, Ex-Smokers, and Current Smokers With Axial Spondyloarthritis: Results From the Scotland Registry for Ankylosing Spondylitis.

Jones GT, Ratz T, Dean LE, Macfarlane GJ, Atzeni F.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1407-1413. doi: 10.1002/acr.23157. Epub 2017 Aug 13.

11.

EULAR revised recommendations for the management of fibromyalgia.

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT.

Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. Epub 2016 Jul 4. Review.

12.

Differences in the prevalence of ankylosing spondylitis in primary and secondary care: only one-third of patients are managed in rheumatology.

Dean LE, Macfarlane GJ, Jones GT.

Rheumatology (Oxford). 2016 Oct;55(10):1820-5. doi: 10.1093/rheumatology/kew228. Epub 2016 Jun 27.

PMID:
27354690
13.

Management of Widespread Pain and Fibromyalgia.

Whibley D, Dean LE, Basu N.

Curr Treatm Opt Rheumatol. 2016;2(4):312-320. doi: 10.1007/s40674-016-0056-5. Epub 2016 Oct 13. Review.

14.

A possible link between ankylosing spondylitis and periodontitis: a systematic review and meta-analysis.

Ratz T, Dean LE, Atzeni F, Reeks C, Macfarlane GJ, Macfarlane TV.

Rheumatology (Oxford). 2015 Mar;54(3):500-10. doi: 10.1093/rheumatology/keu356. Epub 2014 Sep 10. Review.

PMID:
25213130
15.

Global prevalence of ankylosing spondylitis.

Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ.

Rheumatology (Oxford). 2014 Apr;53(4):650-7. doi: 10.1093/rheumatology/ket387. Epub 2013 Dec 9. Review.

PMID:
24324212
16.

Is radiation-free diagnostic monitoring of adolescent idiopathic scoliosis feasible using upright positional magnetic resonance imaging?

Diefenbach C, Lonner BS, Auerbach JD, Bharucha N, Dean LE.

Spine (Phila Pa 1976). 2013 Apr 1;38(7):576-80. doi: 10.1097/BRS.0b013e318286b18a.

PMID:
23324938
17.

Maximal pulmonary recovery after spinal fusion for adolescent idiopathic scoliosis: how do anterior approaches compare?

Verma K, Lonner BS, Kean KE, Dean LE, Valdevit A.

Spine (Phila Pa 1976). 2011 Jun 15;36(14):1086-95. doi: 10.1097/BRS.0b013e3182129d62.

PMID:
21301397
18.

Aortic occlusion causing ischemic neuropathy and paraparesis.

Le DA, Traynor EN, Ghazvini A.

Neurology. 2004 Nov 23;63(10):1984. No abstract available.

PMID:
15557539
19.

Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation.

Le DA, Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, Hyman BT, Yuan J, Kuida K, Flavell RA, Moskowitz MA.

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15188-93. Epub 2002 Nov 1.

20.

Lipid-sugar particles for intracranial drug delivery: safety and biocompatibility.

Kohane DS, Plesnila N, Thomas SS, Le D, Langer R, Moskowitz MA.

Brain Res. 2002 Aug 16;946(2):206-13.

PMID:
12137923
21.

Neurotrophin-3 promotes cell death induced in cerebral ischemia, oxygen-glucose deprivation, and oxidative stress: possible involvement of oxygen free radicals.

Bates B, Hirt L, Thomas SS, Akbarian S, Le D, Amin-Hanjani S, Whalen M, Jaenisch R, Moskowitz MA.

Neurobiol Dis. 2002 Feb;9(1):24-37.

PMID:
11848682

Supplemental Content

Loading ...
Support Center